BIOMAT Database Logo BIOMAT Database Logo

[Catabolic stress to nitrogen (N) metabolism and essential amino acid (EAA) supplementation in hemodialysis (HD)]. 1982

Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009584 Nitrogen An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000601 Amino Acids, Essential Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs. Essential Amino Acid,Essential Amino Acids,Acid, Essential Amino,Acids, Essential Amino,Amino Acid, Essential

Related Publications

Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Oral essential amino acid supplementation in patients on maintenance hemodialysis.
June 1978, Clinical nephrology,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Effect of essential amino acids (EAA) on chronic hemodialysis (CHD) patients (PTS).
January 1982, Transactions - American Society for Artificial Internal Organs,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Effects of essential amino acid (EAA) and glutamine supplementation on skeletal muscle wasting in acute, subacute, and postacute conditions.
May 2024, Clinical nutrition ESPEN,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Loss of amino acids during hemodialysis: effect of oral essential amino acid supplementation.
January 1981, Nephron,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
May 1996, Hepatology (Baltimore, Md.),
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Catabolic stress on intracellular amino acid pool.
January 1984, Advances in experimental medicine and biology,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
[Loss of amino acid during hemodialysis and essential amino acid supplementation in patients on regular dialysis treatment (author's transl)].
November 1977, Nihon Jinzo Gakkai shi,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients.
November 1989, Kidney international. Supplement,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Studies on nitrogen and amino acid metabolism in hemodialysis patients using 15N-labelled compounds.
January 1978, Contributions to nephrology,
Y Tsubakihara, and N Iida, and S Yuasa, and T Kawashima, and I Nakanishi, and T Yokogawa, and M Tomobuchi
Benefit of intravenous essential amino-acids in catabolic patients on chronic maintenance hemodialysis.
January 1991, Acta clinica Belgica,
Copied contents to your clipboard!